2013
DOI: 10.4314/ajid.v7i2.2
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Oraquick® HIV-1/2 as oral rapid test

Abstract: As Cameroon scales up its national HIV/AIDS control program, evaluating the performance of commercially available tests for accurate and cost effective diagnostics becomes essential. A cross-sectional study assessed the performance of an HIV oral rapid test. A total of 1520 participants consented to participate in the study. After counselling, they were tested for HIV using the national algorithm followed by OraQuick. Results of the national algorithm were compared to those of OraQuick, for sensitivity, specif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 10 publications
0
13
0
Order By: Relevance
“…Screening for HIV sero-status was performed using OraQuick HIV (Ora Sure Technology, USA) test kits, as described by the manufacturer and as previously reported [7].…”
Section: Methodsmentioning
confidence: 99%
“…Screening for HIV sero-status was performed using OraQuick HIV (Ora Sure Technology, USA) test kits, as described by the manufacturer and as previously reported [7].…”
Section: Methodsmentioning
confidence: 99%
“…Participants in the HIV self‐testing intervention arms received either an HIV self‐test kit or a coupon for an HIV self‐test kit from their peer educator shortly after enrolment and again three months later. We used the OraQuick Rapid HIV‐1/2 Antibody Tests (OraSure Technologies, Bethlehem, PA) in this study, which have 93% sensitivity and 99% specificity compared to standard‐of‐care blood‐based HIV testing . All participants were trained by an FSW peer educator on how to use and interpret the HIV self‐test results.…”
Section: Methodsmentioning
confidence: 99%
“…More false–positive tests were observed in this study than true–positive tests, yielding a positive predictive value (PPV) of ∼47%. This was much lower than the performance characteristics reported by the manufacturer and others including in low‐risk populations 10,40,41 . However, multiple “real‐world” settings have experienced similar issues with false–positives while using the oral version of the OraQuick test 42,43 .…”
Section: Discussionmentioning
confidence: 73%